🔗 Permalink

Assignee profile:

Biotempt B.V.

City:

Koekange

Country:

Netherlands

Published Applications:

Last publication date:

2011-05-05

Patent Grants:

Last grant date:

2012-10-16

Top Inventors for applications by Biotempt B.V.

These are the the leading inventors for applications assigned to Biotempt B.V.:

Robbert Benner 19 Barendrecht, Netherlands
Nisar Ahmed Khan 15 Rotterdam, Netherlands
Nisar A. Khan 5 Rotterdam, Netherlands
Robert Benner 4 Barendrecht, Netherlands

Richard Michael Carlton 3 Washington, NY United States
Gert Wensvoort 3 Koekange, Netherlands
Nisar Asmed Khan 3 Rotterdam, Netherlands
Bartholomeus Caspar J. Jacobs 1 Rotterdam, Netherlands

Richard Michael Cariton 1 Washington, NY United States
Johannes N. M. Yzermans 1 Rotterdam, Netherlands
Leonie A. Boven 1 Rotterdam, Netherlands
Hubertus Franciscus Josef Savelkoul 1 Oud-Beijerland, Netherlands

Recent patent applications by Biotempt B.V.

Biotempt B.V. based in Koekange, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2011-05-05

US20110105415A1

Chemistry; metallurgy

Gene regulator

#2 | 2011-01-13

US20110009344A1

Human necessities

Control of radiation injury

#3 | 2009-11-26 ✅ Patent 8,288,341 granted on 2012-10-16

US20090291901A1

Human necessities

Control of radiation injury

#4 | 2009-11-12

US20090281033A1

Human necessities

Control of radiation injury

#5 | 2009-07-14 ✅ Patent 7,560,433 granted on 2009-07-14

US10409630

Treatment of multiple sclerosis (MS)

#6 | 2009-04-28 ✅ Patent 7,524,820 granted on 2009-04-28

US11346761

Compounds of therapeutic value in the treatment of multiple sclerosis and other diseases wherein foamy cells are involved in the disease etiology

#7 | 2009-03-10 ✅ Patent 7,501,391 granted on 2009-03-10

US10409027

Treatment of transplant survival

#8 | 2008-10-30

US20080267936A1

Human necessities

Treatment of trauma-hemorrhage with short oligopeptides

#9 | 2008-07-24

US20080176243A1

Chemistry; metallurgy

Gene regulator

#10 | 2008-07-22 ✅ Patent 7,402,322 granted on 2008-07-22

US10678995

Methods of treatment for septic shock with urine extract

#11 | 2008-07-17 ✅ Patent 7,786,084 granted on 2010-08-31

US20080171094A1

Chemistry; metallurgy

Treatment of burns

#12 | 2008-04-29 ✅ Patent 7,365,155 granted on 2008-04-29

US10262522

Immunoregulator

#13 | 2008-04-15 ✅ Patent 7,358,330 granted on 2008-04-15

US10753510

Immunoregulatory compositions

#14 | 2008-03-27

US20080076714A1

Human necessities

Administration of gene-regulatory peptides

#15 | 2008-01-31 ✅ Patent 7,795,226 granted on 2010-09-14

US20080027007A1

Human necessities

Control of radiation injury

#16 | 2007-09-20 ✅ Patent 7,576,174 granted on 2009-08-18

US20070219138A1

Chemistry; metallurgy

Compositions capable of reducing elevated blood urea concentration

#17 | 2007-08-23 ✅ Patent 8,680,059 granted on 2014-03-25

US20070197447A1

Chemistry; metallurgy

Oligopeptide acetate and formulations thereof

#18 | 2007-03-08 ✅ Patent 8,216,998 granted on 2012-07-10

US20070054860A1

Chemistry; metallurgy

Treatment of ischemic events

#19 | 2007-02-13 ✅ Patent 7,175,679 granted on 2007-02-13

US10029206

Oligopeptide treatment of NF-κB mediated inflammation

#20 | 2007-01-25 ✅ Patent 7,662,776 granted on 2010-02-16

US20070021347A1

Human necessities

Treatment of tumors using short peptides from human chorionic gonadotropin (HCG)

#21 | 2006-05-25 ✅ Patent 7,517,529 granted on 2009-04-14

US20060111292A1

Human necessities

Treatment of type I diabetes

#22 | 2005-06-02 ✅ Patent 7,820,617 granted on 2010-10-26

US20050119184A1

Chemistry; metallurgy

Methods of selecting immunoregulator peptides obtained from gonadotropins

#23 | 2005-02-17

US20050037430A1

Chemistry; metallurgy

Methods and uses for protein breakdown products

AssigneeID:

200480 ⎘